Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients At Risk.

NACompletedINTERVENTIONAL
Enrollment

646

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

September 13, 2023

Study Completion Date

May 28, 2024

Conditions
Streptococcus Pneumoniae Infection
Interventions
OTHER

Structured medico-pharmaceutical collaboration

Reconciliation of drug treatments; Writing of the prescription for discharge from hospital for the pneumococcal vaccine; Pharmaceutical interview at discharge; Drafting of the discharge letter and transmission to the attending physician; Writing of the pharmaceutical discharge letter and transmission to the pharmacist; Pharmaceutical dispensing in the pharmacy; Administration of the vaccine by the attending physician or a nurse at home.

Trial Locations (9)

Unknown

CH Alès Cévennes, Alès

CH de Bagnols sur Cèze, Bagnols-sur-Cèze

CH de Montauban, Montauban

CHU de Montpellier, Montpellier

CHU de Nimes, Nîmes

CH de Perpignan, Perpignan

CH Comminges Pyrénées, Saint-Gaudens

CH du Bassin de Thau, Sète

CHU de Toulouse, Toulouse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER